BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
88 hedge funds and large institutions have $78.2M invested in BioDelivery Sciences International, Inc. in 2016 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 35 reducing their positions, and 32 closing their positions.
13% less call options, than puts
Call options by funds: $520K | Put options by funds: $601K
16% less funds holding
Funds holding: 105 → 88 (-17)
37% less capital invested
Capital invested by funds: $124M → $78.2M (-$45.9M)
37% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 35
47% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 32
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.98M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.86M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.46M |
| 4 |
Millennium Management
New York
|
+$967K |
| 5 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$927K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$9.56M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$2.98M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.91M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.76M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.65M |
BDSI Hedge Fund Activity: Q2 2016 in Review
88 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2016, worth a combined $78.2M — down 37% from $124M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of BDSI and 17 opened new positions — a net loss of 15 holders — while 35 trimmed existing stakes and 22 added.
The largest buyer was Renaissance Technologies, adding an estimated $2.98M. The largest seller was Federated Hermes, exiting entirely with an estimated $9.56M sold.
- 88 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2016, down from 105 in Q1 2016.
- Funds reported $78.2M of BioDelivery Sciences International, Inc. stock for Q2 2016, down 37% quarter-over-quarter.
- 17 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2016 and 32 closed out, a net change of -15 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q2 2016 was Renaissance Technologies, an estimated $2.98M added.
- The largest BioDelivery Sciences International, Inc. seller in Q2 2016 was Federated Hermes, an estimated $9.56M sold.
Based on aggregated 13F filings for Q2 2016.